CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
KIR2DL3+ NKG2A- Natural Killer Cells Protect People who Inject Drugs against Productive Hepatitis C Virus Infection
DOI 10.1055/s-0033-1361036
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Thoens, C Berger, M Trippler, H Siemann, M Lutterbeck, R Broering, JF Schlaak, FM Heinemann, A Heinold, J Nattermann, N Scherbaum, G Alter, J Timm
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Despite continuous high-risk behavior, a subgroup among people who inject drugs (PWID) remains seronegative for hepatitis C virus (HCV) suggesting that a state of “natural resistance” to HCV infection may exist. Homozygosity for KIR2DL3 and its ligand HLA-C1 group alleles has been associated with control of HCV infection, however, the mechanism mediating this protective effect remained unclear. In this study we aime…
Zitieren
Zitierempfehlung
C Thoens, C Berger, M Trippler, H Siemann, M Lutterbeck, R Broering, JF Schlaak, FM Heinemann, A Heinold, J Nattermann, N Scherbaum, G Alter, J Timm (2014) KIR2DL3+ NKG2A- Natural Killer Cells Protect People who Inject Drugs against Productive Hepatitis C Virus Infection. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0033-1361036
Mit CareLit weiterarbeiten